America Great Health (AAGH)
America Great Health operates in the Biotechnology industry of the Healthcare sector, headquartered in Alhambra, CA, US. The stock last traded at $0.00, down 33.33% on the session, giving a market capitalisation of $4.2M. On trailing twelve-month figures it carries a trailing P/E of 2.00, a net margin of 175.3%. Its beta of 5.96 implies it has historically moved more than the broad market.
Operating as a U.S.-based biotechnology company, America Great Health (AAGH) focuses on two primary areas: the research and development of protein and peptide small molecular drugs, and the manufacturing and sale of a diverse portfolio including AI cloud computing-driven diagnostic and medical devices, cell therapies, regenerative medicine, and supplements. The company, which originated as Crown Marketing, adopted the name America Great Health in March 2017. Established in 2013, AAGH's headquarters are located in Alhambra, California.
America Great Health is most often compared with the following Healthcare names: